Descripción de negocio
Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Consejo de gestión & Consejo de supervisión
| CEO |
| Adam Steensberg |
| Consejo de gestión |
| Henriette Wennicke, David Kendall, Ivan Møller, Christina Sonnenborg Bredal , Ravinder Chahil |
| Consejo de supervisión |
| Martin Nicklasson, Kirsten A. Drejer, Jeffrey Berkowitz, Bernadette Connaughton, Leonard Kruimer, Alain Munoz, Michael John Owen, Frederik Barfoed Beck, Anneline Nansen, Louise Gjelstrup, Jens Peter Stenvang, Enrique Conterno, Elaine Sullivan |
Datos de la empresa
| Nombre: |
Zealand Pharma A/S |
| Dirección: |
Sydmarken 11,2860 Søborg |
| Teléfono: |
- |
| Fax: |
- |
| E-mail: |
+45 88 77 36 00
|
| Internet: |
info@zealandpharma.com |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
- |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
- |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Anna Krassowska |
| IR teléfono: |
- |
| IR-fax: |
- |
| IR e-mail: |
ank@zealandpharma.com
|
